tissue after storage at -20°C, this could happen with the progesterone receptors of the pulmonary tissue.
Despite full anticoagulation with both heparin and warfarin she sustained pulmonary emboli and therefore a caval filter was inserted. Full investigations, including total body CT, full abdominal and pelvic ultrasound, failed to detect any underlying malignancy. After one month she developed ascites, cytology revealing adenocarcinoma cells from an ovarian primary which was later confirmed ultrasonically. The patient died 3 months later from disseminated malignancy.
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The association between malignant disorders and thromboembolic phenomena was recognized in 1865 when Trousseau reported a high incidence of venous thrombosis in patients with gastric cancer". This relationship is now establishedand has recently been reviewed". True venous gangrene is rare but is usually due to some form of malignant diseasev". We report two patients' who developed venous gangrene necessitating amputation in whom subsequent investigations revealed differing underlying malignant disorders.
Case reports
Case 1: A previously healthy 49-year-old woman was admitted to hospital following a 2 week history ofleft sided pleuritic pain with haemoptysis and a 3 day history of a swollen painful left leg to mid-thigh. Full blood count revealed a haemoglobin of 11.7 g/dl; while cell count of 22.6x 10 9/1 and platelet count of 203x10 9 /1. She was diagnosed as having a deep vein thrombosis with pulmonary embolism and was anticoagulated intravenously with heparin.
Despite adequate therapy she developed progressive phlegmasia caerulia dolens of her left leg within 72 h. Angiography showed total occlusion of the left common iliac vein ( Figure 1 ). In addition, no arterial flow could be demonstrated down the left superficial femoral artery ( Figure 2 ). Fasciotomies revealed dead muscle in both calf and thigh and because the patient's condition was deteriorating a high thigh amputation was performed. Her condition rapidly improved but subsequently the amputation was revised by disarticulation through the hip. discolouration of the right fourth and fifth finger tips was noted. At this stage the patient had normal pulses at the wrist and Doppler studies demonstrated normal digital arterial systolic pressure. The prothrombin time was 13 s (normal 12-14 s) and the partial thromboplastic time was 20 s (normal 21-37 s). The fourth and fifth fingers became gangrenous despite treatment with intravenous heparin (40000 u1day) and amputation of these digits was necessary. Histology of the digits showed extensive venous and capillary thrombosis with normal patent arteries. Postoperatively, intermittent bluish discolouration developed in his remaining fingers and toes and further investigation demonstrated a cryoglobulin. Although there were no clinical features ofa lymphoma, a bone marrow trephine biopsy revealed a well differentiated diffuse lymphocytic lymphoma. The cryoglobulin was 1 gM Kappa. The patient was treated with plasma exchange initially and subsequently by chlorambucil. On this regimen, the level of cryoglobulin fell and his symptoms abated.
Discussion
Two patients have been described who developed venous gangrene secondary to an underlying malignant disorder. The mechanism by which thrombus was generated, however, was quite different.
In the first patient the mechanisms were complex. Abnormalities of blood coagulation tests have been found in up to 92% of patients with cancer, although clinically apparent thrombosis occurs in only 5% of patients'', Malignant cells may release thromboplastic substances into the blood stream or may stimulate circulating monocytes to release a protease that activates the coagulation cascade. In addition thrombocytosis is often observed, and increased thrombopoietic activity has been demonstrated in the serum of some patients with cancer. It seems likely that these mechanisms were responsible for the extensive thrombus formation.
Physical obstruction of iliac vein by the tumour cannot be entirely excluded. However, the tumour was too small to be detected by CT abdominal and pelvic scanning and mechanical obstruction seems improbable.
In the second patient, cryoglobulins were secreted by a malignant clone of lymphoid cells. When exposed to cold, cryoglobulins precipitate, occlude small blood vessels, and thrombosis occurs proximal to the obstruction. Suppression of the malignant clone by chemotherapy reduces the level of cryoglobulin and hence the likelihood of thrombotic episodes.
Treatment of patients with venous gangrene secondary to an underlying malignancy should be aimed primarily at treatment of the cancer. Anticoagulation is required and heparin is the drug of choice. Warfarin is usually ineffective and may be dangerous 9 • 10 • The mortality is high and in one series 83% of 158 patients presenting with venous gangrene died despite intensive treatment with anticoagulants and amputation. The second patient illustrates that the underlying malignancy may be treatable and all patients presenting in this manner should be extensively and repeatedly investigated until an underlying cause is found. It is also important to exclude benign causes of venous gangrene such as polycythaemia ruba vera.
